← Back to Search

Behavioural Intervention

ICAN Health System Intervention for Rural Cancer Care Quality

N/A

Waitlist Available

Research Sponsored by Mary Charlton

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 36 months post implementation of intervention

Awards & highlights

Study Summary

This trial will measure the impact of providing ongoing support to rural hospitals in Iowa to help them meet quality standards for cancer care, and assess implementation and acceptability of the intervention.

Who is the study for?

This trial is for administrators, clinicians, and data monitoring staff involved in cancer care at one of the four selected hospitals. It aims to improve quality standards in rural hospitals that have not been accredited by the Commission on Cancer.Check my eligibility

What is being tested?

The Iowa Cancer Affiliate Network (ICAN) intervention is being tested. It involves education, training, regular check-ins with hospital stakeholders via in-person and Zoom meetings, and resources to help meet American College of Surgeons' cancer care standards.See study design

What are the potential side effects?

Since this study focuses on a health system intervention rather than a medical treatment or drug, it does not involve typical side effects associated with medications. However, changes in workflow or processes may cause temporary adjustment challenges.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 36 months post implementation of intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~36 months post implementation of intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and 36 months post implementation of intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Compliance with CoC quality of cancer care measures: 12 regional lymph nodes (12RLN)

Compliance with CoC quality of cancer care measures: Hormone therapy (HT)

Secondary outcome measures

Compliance with CoC quality of cancer care measures: Adjuvant chemotherapy (ACT)

Compliance with CoC quality of cancer care measures: Breast conserving surgery radiation therapy (BCSRT)

Compliance with CoC quality of cancer care measures: Multi-agent chemotherapy (MAC)

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention Hospital Administrators, Providers, and Data Monitoring StaffExperimental Treatment1 Intervention

This is a health-system-level intervention, designed as two-arm intervention trial, where four participating hospitals will be offered support in the areas of training and education, cancer data collection and reporting, quality improvement and clinical peer-to-peer support. Hospitals that are eligible for the intervention had to be located in an Iowa county classified as non-metropolitan according to rural urban continuum codes (RUCC) 4 through 9 and diagnose or treat at least 100 cancer patients each year. We selected 4 of the 9 rural hospitals meeting this criteria to administer the intervention.

Group II: Control armActive Control1 Intervention

Hospitals that are eligible for the intervention had to be located in an Iowa county classified as non-metropolitan according to rural urban continuum codes (RUCC) 4 through 9 and diagnose or treat at least 100 cancer patients each year. The remaining 5 hospitals meeting this criteria that were not selected for the intervention will serve as controls.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Mary CharltonLead Sponsor

National Cancer Institute (NCI)NIH

13,657 Previous Clinical Trials

40,933,636 Total Patients Enrolled

Media Library

Iowa Cancer Affiliate Network (ICAN) (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05645328 — N/A

Cancer Research Study Groups: Control arm, Intervention Hospital Administrators, Providers, and Data Monitoring Staff

Cancer Clinical Trial 2023: Iowa Cancer Affiliate Network (ICAN) Highlights & Side Effects. Trial Name: NCT05645328 — N/A

Iowa Cancer Affiliate Network (ICAN) (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05645328 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this clinical trial limit participation to individuals under 25 years of age?

"This clinical trial strictly requires that participants must be over 18 years old and no older than 100."

Answered by AI

Is there still availability for individuals to join this clinical trial?

"Information on clinicaltrials.gov reveals that this study is open for recruitment and was first launched on January 20th, 2023 with the latest edit occurring April 19th of the same year."

Answered by AI

How many participants are being welcomed into this research program?

"Affirmative. Data hosted on clinicaltrials.gov attests that this scientific investigation, which was initially published on January 20th 2023, is actively enrolling participants. Approximately a hundred patients must be recruited from one medical site."

Answered by AI

What aim is the trial attempting to achieve?

"This clinical trial, lasting about 36 months post-intervention, seeks to evaluate the compliance with CoC quality of cancer care measures: Hormone therapy (HT). Additionally, investigators will assess Compliance with CoC quality of cancer care measures: Adjuvant chemotherapy (ACT), Percentage of CoC evidence-based standards of cancer care implemented and Compliance with CoC quality of cancer care measures: Multi-agent chemotherapy (MAC) as secondary objectives."

Answered by AI

Is it feasible for me to partake in this medical research endeavor?

"This research trial is searching for candidates suffering from cancer, aged between 18 and 100 years old. Approximately one hundred individuals are needed to partake in this medical study."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Implementation of a Health System Intervention to Improve Quality of Cancer Care for Rural Patients

Mary Charlton 2023. "Implementation of a Health System Intervention to Improve Quality of Cancer Care for Rural Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05645328.